We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


10 Dec 2013 By Olaf Storbeck

The hedge fund has amassed enough votes to block McKesson’s $8 bln takeover bid. The U.S. offer for the German drug wholesaler does look a bit stingy. But Elliott will suffer if the deal fails – so McKesson can probably hold firm. Elliott has other ways to make money here.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)